PRESENTATIONS

PIPELINE PRESENTATIONS

Current Status of Clinical Trials on FAP Targeted Radiopharmaceuticals

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
Gordon Research Conference-Radionuclide Theranostics for the Management of Cancer – Newry, Maine
2022 Annual SNMMI Meeting – Vancouver, Canada
July 19, 2022

FAP Current State

FAP Ligands for Imaging and Therapy

SOFIE/Clovis Oncology/POINT Biopharma
Satellite Symposium, 2022 Annual SNMMI Meeting – Vancouver Canada
June 12, 2022

FAP Ligands for Imaging and Therapy

FAP-Ligand PET Update ≠ Cancer

Presented by: Professor Jeremie Calais, MD, MSc, Professor, University of California, Los Angeles
2022 Annual SNMMI Meeting – Vancouver, Canada
June 12, 2022

FDG Uptake

SOFIE FAPI Clinical Development Update

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
2022 Annual SNMMI Meeting – Vancouver, Canada
June 12, 2022

Webinar: Fibroblast Activation Protein (FAP) – A promising target for radiopharmaceuticals

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
June 8, 2022

2019 SNMMI Image of the Year

Presented by: Professor Frederik L. Giesel, MD, MBA, University Hospital Düsseldorf, Germany
2019 Annual SNMMI Meeting – Anaheim, CA
June 25, 2019

CONTACT US

Are you a pharmaceutical company or distribution network interested obtaining FAPI for your projects and patients? We are eager to learn more about how our compounds can facilitate your needs.